Correction Notice for “First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis” by McLaren et al

Correction Notice for “First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis” by McLaren et al

Bibliographic Details
Format:	Article
Language:	English
Published:	Innovative Healthcare Institute 2021-08-01
Series:	Journal of Immunotherapy and Precision Oncology
Online Access:	https://jipo.org/doi/pdf/10.36401/JIPO-21-CX3

Similar Items

First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis
by: Alistair McLaren, et al.
Published: (2021-08-01)

The Perilous Road to Justice: An Interview with Prof. Peter McLaren
by: Peter McLaren
Published: (2021-04-01)

Análise do som em Dots de Norman McLaren
by: Maria Kauffmann, et al.
Published: (2020-02-01)

Report on professional attachment with Stephen McLaren Consultants Pte Ltd (BL Ong and Co).
by: Koh, Kah Li.
Published: (2008)

La Educación como una cuestión de clase. Entrevista al especialista/autor Peter McLaren
Published: (2013-01-01)

Por uma Pedagogia Crítica: confluências entre as teorizações de Peter McLaren e o pensamento freireano
by: Peter McLaren, et al.
Published: (2022-04-01)

The Role of Critical Pedagogy in the Globalization Era and the Aftermath of September 11, 2001. Interview with Peter McLaren (Updated Version)
by: Lucía Coral Aguirre Muñoz
Published: (2003-05-01)

La Educación como una cuestión de clase. Entrevista al especialista/autor Peter McLaren .Obert,G. y Eliggi,G (Traductoras) / Education as class warfare. An interview with scholar/author Peter McLaren .Obert,G. y Eliggi,G (Translator)
by: Peter Mclaren
Published: (2014-01-01)

Education as Class Warfare. An interview with scholar/author Peter McLaren / La Educación como una cuestión de clase.
by: Peter Mclaren
Published: (2014-01-01)

BEING, BECOMING AND BREAKING-FREE: PETER MCLAREN AND THE PEDAGOGY OF LIBERATION SER LIBRE, ACTUAR CON LIBERTAD Y LIBERARSE. PETER McLAREN Y LA PEDAGOGÍA DE LA LIBERACIÓN
by: Peter McLaren.
Published: (2009-11-01)

Reseña de "PEDAGOGÍA CRÍTICA. DE QUÉ HABLAMOS , DÓNDE ESTAMOS" Peter McLaren y Joe L. Kincheloe (Eds.)
by: Laura Ruiz
Published: (2010-01-01)

Wallerstein, l., lmpensar las ciencias sociales ; McLaren, P., Multiculturalismo revolucionario. Pedagogía de disensión para un nuevo milenio
by: Luis Armando González
Published: (2001-04-01)

<b>Margaret A. McLaren</b>, <i>Feminism, Foucault, and Embodied Subjectivity</i> (Albany, NY: SUNY Press, 2007). ISBN: 0791455149
by: Ellen K Feder
Published: (2009-02-01)

PARPi-FL - a Fluorescent PARP1 Inhibitor for Glioblastoma Imaging
by: Christopher P. Irwin, et al.
Published: (2014-05-01)

Mc Laren : the grand prix, CanAm and Indy cars /
by: 277161 Nye, Doug
Published: (1988)

PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
by: Ramya Ambur Sankaranarayana, et al.
Published: (2022-09-01)

Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
by: Ramya Ambur Sankaranarayanan, et al.
Published: (2023-02-01)

Pérez Baltodano, A. (ed.), Globalización, ciudadanía y política social en América Latina ; Fyte, J.J.; Greene, J.R.; Walsh, W.F.; Wilson, O. W. y McLaren, R.C., Administración de la polícia
by: Luis Armando González
Published: (1998-12-01)

BEING, BECOMING AND BREAKING-FREE: PETER MCLAREN AND THE PEDAGOGY OF LIBERATION
by: Peter McLaren.
Published: (2009-11-01)

Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia
by: John P. Brabson, et al.
Published: (2023-01-01)

SA 5.1 Post-neoadjuvant options in triple negative disease: PARPi, capecitabine, checkpoint inhibitors
by: J. Cortes
Published: (2023-03-01)

HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients
by: Lei Li, et al.
Published: (2023-05-01)

[18F]PARPi Imaging Is Not Affected by HPV Status In Vitro
by: Navjot Guru, et al.
Published: (2021-01-01)

Use of First-Line PARP Inhibitors in Ovarian Cancer
by: Ursula Hasler-Strub
Published: (2020-11-01)

Use of First-Line PARP Inhibitors in Ovarian Cancer
by: Ursula Hasler-Strub
Published: (2020-11-01)

Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer
by: Daniel Martin Klotz, et al.
Published: (2023-07-01)

Discovery of Novel 4-Hydroxyquinazoline Derivatives: In Silico, In Vivo and In Vitro Studies Using Primary PARPi-Resistant Cell Lines
by: Lijie Zhu, et al.
Published: (2024-03-01)

Ferritin: A Biomarker Requiring Caution in Clinical Decision
by: Baptiste Lemaire, et al.
Published: (2024-02-01)

Serologic Detection of Helicobacter pylori Infection and the Required Cautions
by: Maryam Esmaeili, et al.
Published: (2016-01-01)

Resenha: MCLAREN, Margaret A. Foucault Feminismo e Subjetividade. São Paulo, Intermeios, 2016
by: Bruno Pessoa Villela
Published: (2017-07-01)

Life cycle assessment analysis of kenaf cultivation in bonorowo land, laren, lamongan
by: Desrina Yusi Irawati, et al.
Published: (2019-12-01)

Fully Automated, High-Dose Radiosynthesis of [<sup>18</sup>F]PARPi
by: Anna Pacelli, et al.
Published: (2022-07-01)

Facing inevitable PARPis resistance: Mechanisms and therapeutic strategies for breast cancer treatment
by: Haixia Liu, et al.
Published: (2023-04-01)

Interactions of PARP1 Inhibitors with PARP1-Nucleosome Complexes
by: Natalya Maluchenko, et al.
Published: (2022-10-01)

Caution is required for the evaluation of the accuracy of continuous glucose monitoring devices
by: Yushi Hirota, et al.
Published: (2020-01-01)

Natural phytochemicals prevent side effects in BRCA-mutated ovarian cancer and PARP inhibitor treatment
by: Chuanlin Wang, et al.
Published: (2022-12-01)

Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD
by: Hewitt, G, et al.
Published: (2020)

Enhance PARPi Application beyond BRCA-Mutant Breast Cancer (BC): Facts Are Facts
by: Tania Di Raimo, et al.
Published: (2020-07-01)

Dual Inhibitors of PARPs and ROCKs
by: Albert A. Antolín, et al.
Published: (2018-10-01)

Virtual screening for plant PARP inhibitors – what can be learned from human PARP inhibitors?
by: Heym Peter-Paul, et al.
Published: (2012-05-01)